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http://dx.doi.org/10.1016/j.fjs.2012.Summary Endoscopic biliary stenting is a well-established therapeutic option for biliary
decompression in patients with a high operative risk. One of the major drawbacks of the proce-
dure is distal migration. We present a patient who suffered from two episodes of gastrointes-
tinal bleeding after biliary endoprosthesis placement. In the first episode, bloody stool passage
occurred 1 day after the procedure. Hemobilia was diagnosed after endoscopic study. The
bleeding source in the second episode, however, was later found to be erosion in the ascending
colon as a late sequela of stent migration. The signs and symptoms in the two different-source
bleeding episodes occurred consecutively, and were clinically similar. Therefore, the differen-
tial diagnosis in such a case might be difficult. Only with a high index of suspicion, which we
used in this case, can the prompt diagnosis and optimal treatment be achieved.
Copyright ª 2012, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Although biliary stenting is a low-risk procedure compared
with surgical treatment, it is complicated by pancreatitis
(5.4%), cholangitis (<5%), hemorrhage (<2%), or gastroin-
testinal perforation (<1%).1 Iatrogenic hemobilia after thiseneral Surgery, Department
pital, Kaohsiung, 123 Ta Pei
33, Taiwan.
om (S.-M. Sheen-Chen).
ight ª 2012, Taiwan Surgical Asso
06.004procedure is uncommon, though it tends to increase
because of widespread use of invasive procedures. Stent-
associated complications include migration, perforation,
bleeding, and obstruction. While distal stent migration is
relatively common and accounts for approximately 6% of all
patients undergoing the procedure, stent-related bleeding
is uncommon (1.25%).2e5 The most common site of
a migrated biliary stent is the duodenum, whereas the small
bowel or colon is rare. A migrated stent stuck into the
ascending colon resulting in erosion accompanied by
hemorrhagic shock has not been reported. We report,
therefore, an intriguing case that underwent biliaryciation. Published by Elsevier Taiwan LLC. All rights reserved.
158 T.-M. Hsieh, S.-M. Sheen-Chenstenting on account of common bile duct stone with
obstructive jaundice, and then suffered from hemobilia
after stenting. Recurrent gastrointestinal hemorrhage from
distal stent migration caused the second episode of
gastrointestinal hemorrhage that was treated as recurrent
hemobilia. The case emphasizes that surgeons should have
a high index of suspicion for stent-related complications
and also emphasizes the need for meticulous evaluation of
gastrointestinal bleeding and stent position in patients who
have had biliary endoprosthesis placement.Figure 1 Plain chest film shows the presence of PTGBD
catheter (single arrow) and biliary stent up to the left intra-
hepatic duct for biliary decompression (double arrows).
PTGBD Z percutaneous transhepatic gallbladder drainage.
Figure 2 Upper gastrointestinal endoscopic picture shows
fresh blood oozing from the ampullary orifice.2. Case report
A 60-year-old man suffered from an episode of right upper
quadrant abdominal pain with a distended gallbladder
containing gallstones. Percutaneous transhepatic gall-
bladder drainage (PTGBD) was performed under the initial
diagnosis of acute cholecystitis. However, progressive
jaundice developed, and he was transferred to our
hospital/department from a local medical department.
Pertinent data on serum chemistries were as follows: total
bilirubin 28 mg/dL (normal range, 0.2e1.4), aspartate
aminotransferase 41 U/L (normal range, 0e37), alanine
aminotransferase 61 U/L (normal range, 0e40), and alka-
line phosphatase 139 U/L (normal range, 28e94). Leuko-
cytosis of 39,000/mL (normal range, 3900e10,600) with
a left shift, a mildly decreased hemoglobulin (Hb) level of
12.2 g/dL (normal range, 13.5e17.5), and an elevated C-
reactive protein of 168 mg/L (normal range, <5) were also
noted. Intravenous ceftriaxone at a dose of 1 g every 12
hours was given under the impression of acute cholangitis
with obstructive jaundice. Endoscopic retrograde chol-
angiopancreatography (ERCP) demonstrated a dilated
common bile duct, purulent bile, and multiple ductal
stones. An 8.5 French 12 cm plastic biliary stent was then
placed without sphincterotomy up to left intrahepatic
duct for temporary biliary decompression (Fig. 1).
Two days after ERCP, the patient complained of
abdominal pain and bloody stools. Bloody drainage from the
PTGBD catheter was also noted. After conservative treat-
ment, the condition showed no improvement, with persis-
tent mild bloody stool passage and a progressively falling
hemoglobin level down to 8.7 g/dL. Upper gastrointestinal
endoscopy revealed a normal stomach, but fresh oozing and
blood clots at the ampullary orifice (Fig. 2). After active
resuscitation with tranexamic acid, vitamin K1, and fresh
frozen plasma infusion, hemobilia was improved gradually
without further bloody or tarry stool passage. Then he was
discharged temporarily with total bilirubin and Hb levels at
4.8 mg/dL and 10.1 g/dL, respectively.
Five days after discharge, he visited our emergency
room due to abdominal pain, fever, and progressive amount
of bloody stool. Serum biochemical studies revealed a total
bilirubin level of 7.7 mg/dL, a hemoglobin concentration of
8.0 g/dL, a white blood count of 15,600/mL, and a C-reac-
tive protein level of 47 mg/L. Under the preliminary diag-
nosis of cholangitis with recurrent hemobilia, parenteral
ceftriaxone and blood components were given. Hemody-
namic instability was followed by a rapid deterioration for
which an emergent angiographic study was performed, but
it showed no active bleeder. After active resuscitation,gastrointestinal bleeding persisted with recurrent bloody
stool passage and hypotension (BP: 84/53 mmHg; Hb: 6.5 g/
dL). A repeated emergent angiogram again demonstrated
no identifiable bleeding source. Upper gastrointestinal
endoscopy merely showed several shallow gastric ulcers
without active bleeding. Despite intermittent bloody stool
Figure 4 Abdominal CT shows the impacted biliary stent
inside the ascending colon (arrow). CT Z computed
tomography.
Biliary stent-induced colonic hemorrhage 159passage, hemodynamic stability was resumed after
aggressive fluid resuscitation. A plain abdominal film later
showed abnormal location of the stent in the right iliac
fossa (Fig. 3), which gave the impression of stent migration.
Subsequent abdominal computed tomography (CT)
revealed stent impaction at the ascending colon without
any evidence of abnormal peritoneal fluid or gas accumu-
lation suggestive of perforation of the colon or other hollow
organs (Fig. 4). Conservative treatment strategy with
intravenous fluid and transfusion was adopted because of
the CT finding and the absence of peritoneal signs typical of
peritonitis. However, after 3 days of observation and a daily
packed red blood cell transfusion of 500 mL to maintain an
Hb concentration above 9 g/dL, bloody stool passage per-
sisted. As a result, colonoscopy was performed, which
showed embedding of the tip of stent in the wall of
ascending colon at the hepatic flexure, resulting in wall
erosion and bleeding. No sign of diverticulum or other
source of bleeding was evident. After prompt removal of
the stent together with administration of intravenous tra-
nexamic acid and fresh frozen plasma, the patient’s bloody
stool subsided with overall improvement in clinical condi-
tion. Subsequently, he underwent conventional cholecys-
tectomy and choledocholithotomy 5 days later, and made
an uneventful recovery.3. Discussion
The etiology of hemobilia changes with an increase in
incidence from accidental trauma to iatrogenic hemorrhage
due to the widespread use of invasive hepatobiliary
procedures. In reviewing 222 patients of hemobilia from
1996 to 1999, we find that 147 were iatrogenic following
hepatobiliary intervention while accidental trauma
accounted for only 5%.6 Early diagnosis of hemobilia
depends on the level of clinical suspicion. TypicalFigure 3 Plain abdominal film demonstrates abnormal loca-
tion of the stent in the right iliac fossa.manifestations of the triad of abdominal pain (52e70%),
gastrointestinal bleeding (83e93%), and jaundice (30e60%)
may be present in only 22e28% of patients.6 As a result, our
patient was suspected to have “recurrent hemobilia” as he
visited our emergency room the second time presenting
with the typical triad.
Hemobilia is not usually considered a clinically signifi-
cant entity as it is a rare cause of gastrointestinal bleeding.
The management of hemobilia aims at hemostasis and
relieving biliary obstruction. Active intervention is indi-
cated for severe or recurrent bleeding. Angiography is
considered the diagnostic tool of choice.6 In our patient,
the initial hemobilia could be due to a combination of
initial uncontrolled sepsis and procedure-related trauma.
Then hemobilia would be self-limited after sepsis control
with decompression of the infected bile and the use of
broad-spectrum antibiotics. Despite untreated chol-
edocholithiasis under the initial critical condition, biliary
stenting apparently relieved the jaundice of the patient
through dislodgment of the impacted stones at the
sphincter of Oddi through which free flow of the infected
bile into the duodenum was possible.
Stent migration has been described either sporadically in
case reports or as an uncommon complication in larger
series.7e9 Johanson et al3 followed 322 biliary stent
placements and found 19 cases (5.9%) of distal stent
migration. Another series of 297 stent placements demon-
strated 11 cases (3.7%) of distal migration.4 Mueller et al5
reported six episodes of distal stent migration in a series
of 102 stentings, giving rise to an incidence of 5.8%. Taken
together, the distal migration rate after stent placement is
around 5%. Most distally migrated stents pass off sponta-
neously. The most common site of a dislodged biliary stent
is the duodenum, whereas impaction in other portions of
small bowel or colon is rare. A variety of injuries have been
reported from stent migration, with bowel perforation
being the most commonly reported one that tends to occur
in patients with diverticular disease, hernia, or intra-
abdominal adhesion.7 None of the above conditions was
applicable to our patient who suffered from colonic erosion
and hemorrhage from a dislodged biliary stent leading to
the impression of recurrent hemobilia.
160 T.-M. Hsieh, S.-M. Sheen-ChenNamdar et al7 have reviewed a series of 11 cases of colon
perforation from biliary stent impaction, all of which
occurred in the sigmoid colon. Although the sigmoid colon
seems to be the most common site of stent-related colon
perforation, sporadic cases of colon perforation at other
sites of the colon have also been reported. Berry et al8 have
described a case of stent migration from the common bile
duct to the transverse colon through chronic erosion and
fistula formation, giving rise to late colonic hemorrhage.
Moreover, colon perforation with abscess formation around
the ascending colon has also been reported in a patient
with a missing stent 2 months after an unsuccessful endo-
scopic biliary stenting.9 Our present case is unique in that
colonic hemorrhage occurred from a dislodged stent
impacted in the ascending colon after a previous episode of
hemobilia. Diller et al10 suggested prompt intervention and
stent removal for symptomatic patients after successful
surgical treatment of five cases of distal biliary stent
migration. In the case of our patient, prompt endoscopic
removal of the impacted stent not only attained hemostasis
successfully under unstable condition despite aggressive
resuscitation, but also prevented further complications
such as perforation and fistula formation. Therefore, our
case also strengthens this proposal further. Hemostasis
after the procedure was possibly due to the removal of the
embedded tip of the stent that not only caused erosion with
active bleeding on the colonic mucosa, but also hampered
the physiological peristalsis of the colon. Hemorrhage from
the lesion may be stopped by unimpeded colonic contrac-
tion after foreign body removal.
While hemobilia after biliary stenting and ascending
colon erosion secondary to distal biliary stent migration are
uncommon complications in patients who have had biliary
endoprosthesis placement, occurrence of the two entities
in succession in the same patient has not been reported.The case presented here should alert clinicians to all
possible stent-related complications that may occur
concomitantly in a single patient. Furthermore, timely
diagnosis and early intervention are mandatory in symp-
tomatic patients in order to prevent further life-
threatening complications.References
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